|
Lipids and Lipid Disorders
Citations 111-120 of 193 total displayed.
|
Past content
(since Jan 1998):
|
- Original Investigations
Acute Myocardial Infarction in Human Immunodeficiency Virus–Infected Patients
- Shlomo Matetzky; Michelle Domingo; Saibal Kar; Marko Noc; Prediman K. Shah; Sanjay Kaul; Eric Daar; Bojan Cercek
Arch Intern Med 2003; 163: 457-460.
[Abstract]
[Full text]
[PDF]
- Review Articles
Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines
- Arshag D. Mooradian
Arch Intern Med 2003; 163: 33-40.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Long-term Compliance With Lipid-Lowering Medication After Genetic Screening for Familial Hypercholesterolemia
- Marina A. W. Umans-Eckenhausen; Joep C. Defesche; Marjel J. van Dam; John J. P. Kastelein
Arch Intern Med 2003; 163: 65-68.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Risk Factors for Coronary Heart Disease in African Americans: The Atherosclerosis Risk in Communities Study, 1987-1997
- Daniel W. Jones; Lloyd E. Chambless; Aaron R. Folsom; Gerardo Heiss; Richard G. Hutchinson; A. Richey Sharrett; Moyses Szklo; Herman A. Taylor Jr
Arch Intern Med 2002; 162: 2565-2571.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Diabetes, Plasma Insulin, and Cardiovascular Disease: Subgroup Analysis From the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)
- Hanna Bloomfield Rubins; Sander J. Robins; Dorothea Collins; David B. Nelson; Marshall B. Elam; Ernst J. Schaefer; Fred H. Faas; James W. Anderson; for the VA-HIT Study Group
Arch Intern Med 2002; 162: 2597-2604.
[Abstract]
[Full text]
[PDF]
- Commentaries
The New National Cholesterol Education Program Guidelines: Clinical Challenges for More Widespread Therapy of Lipids to Treat and Prevent Coronary Heart Disease
- Rachel S. Eidelman; Gervasio A. Lamas; Charles H. Hennekens
Arch Intern Med 2002; 162: 2033-2036.
[Extract]
[Full text]
[PDF]
- Original Investigations
Body Mass Index, Waist Circumference, and Health Risk: Evidence in Support of Current National Institutes of Health Guidelines
- Ian Janssen; Peter T. Katzmarzyk; Robert Ross
Arch Intern Med 2002; 162: 2074-2079.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes: Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial
- Scott M. Grundy; Gloria Lena Vega; Mark E. McGovern; Brian R. Tulloch; David M. Kendall; David Fitz-Patrick; Om P. Ganda; Robert S. Rosenson; John B. Buse; David D. Robertson; John P. Sheehan; for the Diabetes Multicenter Research Group
Arch Intern Med 2002; 162: 1568-1576.
[Abstract]
[Full text]
[PDF]
- Editorials
Statin Therapy in Older Persons: Pertinent Issues
- Scott M. Grundy
Arch Intern Med 2002; 162: 1329-1331.
[Extract]
[Full text]
[PDF]
- Original Investigations
Therapy With Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors (Statins) and Associated Risk of Incident Cardiovascular Events in Older Adults: Evidence From the Cardiovascular Health Study
- Rozenn N. Lemaitre; Bruce M. Psaty; Susan R. Heckbert; Richard A. Kronmal; Anne B. Newman; Gregory L. Burke
Arch Intern Med 2002; 162: 1395-1400.
[Abstract]
[Full text]
[PDF]
|
|
